Two new studies have shed light on the effectiveness of oral probiotic BLIS M18™ in promoting dental health among various age groups. These new findings underscore the potential of BLIS M18™ as a powerful oral probiotic for improving teeth and gum health.

Oral health issues, including dental caries and gum diseases, are primarily attributed to harmful oral bacteria. S. salivarius M18 (BLIS M18™) has shown promising results in inhibiting these bacteria associated with dental problems, as highlighted in the recent studies:

Study 1: published in Nutrients Journal - A clinical trial involving 61 young adults (aged 18-25) revealed significant improvements in gum health markers after a 4-week intervention with BLIS M18™. The intervention group displayed noticeable enhancements in oral hygiene levels and reduced gingival bleeding, indicating improved gum condition.

Study 2: published in Paediatric Dentistry and Dental Prophylaxis - In a year-long examination among 90 preschoolers with dental caries, repeated 3-month applications of BLIS M18™ exhibited substantial improvements in oral health indicators, including notable reductions in caries and gingivitis indices.

These publications reinforce BLIS M18™'s potential in combatting cariogenic bacteria, decreasing inflammatory markers associated with oral health issues, and enhancing gum health in both adults and children, building upon previous scientific research.

"We're excited about the implications of these latest studies, further substantiating the role of BLIS M18™ in oral health improvement," said Chief Technology Officer, John Hale. "The findings reflect a further step forward in validating the efficacy of BLIS M18™ as an effective oral probiotic supplement for teeth and gum health "

For more details on BLIS M18™ and its clinical research, visit www.blis.co.nz.